Steroids, particularly in high doses during the initial post-transplant period, can lead to hypercalcemia by inducing enzymes involved in vitamin D metabolism, which increases both parathyroid hormone and fibroblast growth factor 23 levels [8,9]. This evidence concerns the gene FGF23 and hypercalcemia disease.